NASDAQ:IPHA Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Innate Pharma S.A.
An investor, who purchased shares of Innate Pharma S.A. (NASDAQ:IPHA), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Innate Pharma S.A.
View full press release